These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 31195064)

  • 1. Molecular and histological correlations in liver cancer.
    Calderaro J; Ziol M; Paradis V; Zucman-Rossi J
    J Hepatol; 2019 Sep; 71(3):616-630. PubMed ID: 31195064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma.
    Zhang T; Gu J; Wang X; Lu Y; Cai K; Li H; Nie Y; Chen X; Wang J
    Front Immunol; 2023; 14():1140201. PubMed ID: 36936935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.
    Katoh H; Ojima H; Kokubu A; Saito S; Kondo T; Kosuge T; Hosoda F; Imoto I; Inazawa J; Hirohashi S; Shibata T
    Gastroenterology; 2007 Nov; 133(5):1475-86. PubMed ID: 17983802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in molecular classification and precision oncology in hepatocellular carcinoma.
    Rebouissou S; Nault JC
    J Hepatol; 2020 Feb; 72(2):215-229. PubMed ID: 31954487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
    Ando S; Shibahara J; Hayashi A; Fukayama M
    Virchows Arch; 2015 Nov; 467(5):535-42. PubMed ID: 26311355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.
    An FQ; Matsuda M; Fujii H; Tang RF; Amemiya H; Dai YM; Matsumoto Y
    Int J Cancer; 2001 Aug; 93(4):468-74. PubMed ID: 11477549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification.
    Torbenson M; McCabe CE; O'Brien DR; Yin J; Bainter T; Tran NH; Yasir S; Chen ZE; Dhanasekaran R; Ahn KS; Roberts LR; Wang C
    Hum Pathol; 2022 Jan; 119():15-27. PubMed ID: 34592239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
    Boyault S; Rickman DS; de Reyniès A; Balabaud C; Rebouissou S; Jeannot E; Hérault A; Saric J; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J
    Hepatology; 2007 Jan; 45(1):42-52. PubMed ID: 17187432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
    Charawi S; Just PA; Savall M; Abitbol S; Traore M; Metzger N; Ravinger R; Cavard C; Terris B; Perret C
    J Pathol; 2019 Apr; 247(4):435-443. PubMed ID: 30566242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological indices to predict hepatocellular carcinoma molecular classification.
    Tan PS; Nakagawa S; Goossens N; Venkatesh A; Huang T; Ward SC; Sun X; Song WM; Koh A; Canasto-Chibuque C; Deshmukh M; Nair V; Mahajan M; Zhang B; Fiel MI; Kobayashi M; Kumada H; Hoshida Y
    Liver Int; 2016 Jan; 36(1):108-18. PubMed ID: 26058462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection.
    Désert R; Rohart F; Canal F; Sicard M; Desille M; Renaud S; Turlin B; Bellaud P; Perret C; Clément B; Lê Cao KA; Musso O
    Hepatology; 2017 Nov; 66(5):1502-1518. PubMed ID: 28498607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational analysis of TP53 vs. CTNNB1 mutations in hepatocellular carcinoma suggests distinct cancer subtypes with differential gene expression profiles and chromatin states.
    Biterge Süt B
    Comput Biol Chem; 2020 Dec; 89():107404. PubMed ID: 33096424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
    Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
    Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
    J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.